口臭药物市场（按成分、产品类型、疾病类型和分销管道）—2025-2030 年全球预测

2024 年口臭药物市值为 39.1 亿美元，预计 2025 年将达到 41.8 亿美元，复合年增长率为 7.07%，到 2030 年将达到 59 亿美元。

主要市场统计数据
基准年2024年	39.1亿美元
预计2025年	41.8亿美元
预测年份 2030	59亿美元
复合年增长率（%）	7.07%

透过先进的解决方案、科学创新和多方面的治疗，探索解决持续性口臭的复杂挑战和新方法

口臭，俗称口臭，影响全球相当一部分人口，并且一直是消费者和口腔健康专业人士关注的焦点。口臭的多重因素归因于口腔内复杂的微生物生态系统，挥发性含硫化合物和其他致臭物质在此产生。分析化学的最新进展使得对这些化合物的鑑定更加精确，揭示了厌氧菌在产生最强烈、最持久的恶臭方面所起的作用。此外，患者对口臭的心理和社会反应往往与自我认知和临床评估之间存在差异，这进一步加剧了问题的复杂性，并推动了对更可靠诊断工具的需求。

技术进步、监管环境的变化以及消费行为的转变正在创造一场革命性的运动，重新定义口臭治疗的模式

过去十年，在生物技术突破和消费者对天然个人化解决方案日益增长的需求的推动下，口臭治疗生态系统发生了翻天覆地的变化。肽基抗菌剂和奈米载体递送系统的技术进步使得精准靶向致臭细菌成为可能，从而研发出功效更高、疗效更持久的製剂。同时，人工智慧和机器学习的加速应用增强了微生物组组成的预测模型，使研究人员能够识别高风险族群并相应地制定干预措施。

评估2025年美国关税调整对口腔卫生产品供应链、分销网络和成本结构的深远影响

2025年即将生效的新关税措施的宣布，为全球口气清新成分供应链带来了不确定性。活性成分（尤其是来自主要国际供应商的原料）进口关税的变化，预计将影响原料成本和筹资策略。依赖氯化十六烷基吡啶、三氯生和锌盐等化合物的製造商可能需要重新审视其供应商合同，或在贸易条件更为优惠的国家或地区寻找其他采购管道。这种结构调整不仅会影响成本结构，还会影响生产计划，因为前置作业时间会因物流限製而改变。

揭示成分、产品类型、疾病类型和分销管道的关键市场细分洞察，以指导策略决策

细緻入微地了解市场区隔对于制定产品系列和行销策略至关重要。化学活性剂继续主导成分讨论，例如因其广泛抗菌特性而广受认可的氯化十六烷基吡啶；因其强效抑菌而备受推崇的洛赫西定定；历史上曾用于各种口腔清洁用品配方的三氯生；以及因其气味结合能力而备受推崇的锌盐。同时，随着消费者寻求更清洁的标籤和植物益处，对精油和植物抽取物等天然替代品的需求正在激增。产品细分揭示了快速起效的配方（如用于随时随地清新口气的口气喷雾和口香糖）与针对日常生活习惯的长效护理（如漱口水、含漱液、片剂、含片和传统牙膏）之间的动态平衡。

解读美洲、欧洲、中东和非洲以及亚太地区呼吸管理趋势的区域差异，以指导有针对性的成长策略

随着相关人员根据不同的消费行为、监管环境和经济状况调整策略，区域动态正在塑造全球口臭市场。在美洲，成熟的口腔护理习惯和较高的可支配收入推动了对高端配方的需求，北美消费者尤其容易接受创新的给药系统和经临床检验的产品标籤。拉丁美洲市场的特点是健康意识不断增强，零售通路不断拓展，这为中阶市场品牌提供了抓住新需求的机会。

分析产业领导者、策略联盟和创新轨迹，塑造口臭解决方案领域的竞争格局

市场领导正大力投资研发和策略联盟，以保持竞争优势。现有的化学成分製造商正在与生物技术公司合作，开发新一代抗菌剂，以针对特定的口臭病原体，同时维持有益的口腔微生物群。同时，天然萃取物专家正与学术机构成立合资企业，透过严格的临床试验检验精油和植物衍生物的功效，从而提升消费者信心和监管认可度。

为行业领导者提供策略蓝图，以利用不断发展的口臭治疗领域的新机会并降低风险

要在这种快节奏的环境中取得成功，产业领导者必须实施多管齐下的成长策略，在创新、营运韧性和消费者参与度之间取得平衡。首先，优先投资先进的製剂技术，例如微胶囊技术和缓释系统，可以最大限度地减少给药频率，同时保持新鲜度，从而提升竞争力。此外，透过区域分布的生产设施来提高供应链的灵活性，可以缓衝关税相关的波动，确保产品供应充足和成本稳定。

我们综合的调查方法结合了质性访谈、量化资料分析和多源三角测量，以提供可靠的见解

本报告采用严谨的混合方法，旨在提供可靠且可操作的洞察。主要研究包括对关键意见领袖（包括牙科保健专业人士、配方科学家和供应链专家）进行深入访谈，以捕捉关于新兴趋势、临床疗效基准和商业性创新的细微观点。这些定性资料与广泛的定量资料分析相辅相成，涵盖历史市场绩效指标、成分利用率和电商销售趋势。透过整合不同的资料点，该研究确定了整个口臭治疗生态系统的共同模式和潜在曲折点。

综合主要研究结果与未来展望，阐明口臭管理领域的创新与市场成长途径

综上所述，本研究结果表明，口臭治疗领域正处于曲折点，这得益于科学突破、监管要求的不断变化以及消费者偏好的不断演变。化学和天然活性成分各自提供独特的价值提案，而新的递送技术则兼具功效和便利性。美国即将进行的关税调整凸显了供应链弹性的重要性，而美洲、中东和非洲以及亚太地区的区域差异则凸显了製定针对特定市场的策略的必要性。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

• 旨在恢復健康口腔微生物群的益生菌漱口水的需求日益增长
• 利用人工智慧诊断解决慢性口臭问题的个人化口腔清洁用品方案正在成长
• 消费者健康趋势日益增长，推动口气清新剂转向使用天然植物萃取物
• 漱口水产品现采用环保包装和可再填充形式，以减少塑胶废弃物
• 整合智慧感测器的牙刷，用于即时呼吸监测和回馈
• 扩大订阅制的直接面向消费者的口臭解决方案，推出精选口腔清洁用品套件
• 口腔护理品牌与牙科专业人士加强合作，提供经临床检验的对抗口臭的解决方案
• 加速集美白、缓解牙齿敏感和控制口臭于一体的多功能牙膏的创新

第六章 市场洞察

• 波特五力分析
• PESTEL分析

第七章 2025年美国关税的累积影响

第八章 口气清新剂市场（依成分）

• 化学品
  • 氯化十六烷基吡啶
  • 洛赫西定
  • 三氯生
  • 锌盐
• 自然的
  • 精油
  • 植物萃取物

第九章 口气清新剂市场（依产品）

• 口气清新喷雾
• 口香糖
• 漱口水/漱口水
• 片剂/锭剂
• 牙膏

第十章 口臭药物市场（依疾病类型）

• 真正的口臭
  • 病理性口臭
  • 生理性口臭
• 恐惧症
• 假口臭

第 11 章。口气清新剂市场（依分销管道）

• 离线
  • 百货公司
  • 药局
  • 超级市场
• 在线的
  • 品牌网站
  • 电商平台

第 12 章：美洲口气清新剂市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 阿根廷

第 13 章：欧洲、中东和非洲的口气清新剂市场

• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 阿拉伯聯合大公国
• 沙乌地阿拉伯
• 南非
• 丹麦
• 荷兰
• 卡达
• 芬兰
• 瑞典
• 奈及利亚
• 埃及
• 土耳其
• 以色列
• 挪威
• 波兰
• 瑞士

第 14 章：亚太地区口气清新剂市场

• 中国
• 印度
• 日本
• 澳洲
• 韩国
• 印尼
• 泰国
• 菲律宾
• 马来西亚
• 新加坡
• 越南
• 台湾

第十五章竞争格局

• 2024年市场占有率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Chattem, Inc.
  • Church & Dwight Co., Inc.
  • Colgate-Palmolive Company
  • Dabur India Limited
  • Dentaid SL
  • Dental Herb Company
  • Dr. Harold Katz, LLC
  • GlaxoSmithKline PLC
  • Hello Products LLC
  • Johnson & Johnson
  • Kao Corporation
  • Kerr Corporation
  • Koninklijke Philips NV
  • Lion Corporation
  • OraLabs, Inc.
  • Patanjali Ayurved Ltd.
  • PerioSciences
  • Procter & Gamble Co.
  • Rowpar Pharmaceuticals, Inc
  • Sunstar Suisse SA
  • Tom's of Maine, Inc.
  • Unilever PLC
  • Viatris Inc.
  • Zendium
  • Zila, Inc.

第十六章 研究人工智慧

第十七章 研究统计

第十八章 研究联络人

第十九章 研究报导

第二十章 附录

The Halitosis Agent Market was valued at USD 3.91 billion in 2024 and is projected to grow to USD 4.18 billion in 2025, with a CAGR of 7.07%, reaching USD 5.90 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024]	USD 3.91 billion
Estimated Year [2025]	USD 4.18 billion
Forecast Year [2030]	USD 5.90 billion
CAGR (%)	7.07%

Exploring the Complex Challenges and Emerging Approaches in Addressing Persistent Halitosis Through Advanced Solutions, Scientific Innovations, and Multidimensional Therapies

Breath malodor, typically known as halitosis, affects a substantial segment of the global population and remains a persistent concern for both consumers and oral health professionals. The multifactorial nature of this condition stems from complex microbial ecosystems within the oral cavity where volatile sulfur compounds and other malodorous byproducts are generated. Recent advances in analytical chemistry have enabled more precise identification of these compounds, illuminating the role of anaerobic bacteria in producing the most potent and persistent odors. Moreover, patient psycho-social responses to halitosis create an additional layer of complexity as self-perception often diverges from clinical assessments, driving demand for more reliable diagnostic tools.

In response to these challenges, cross-disciplinary research has accelerated the exploration of novel therapeutic modalities. Innovations range from microbiome-targeted formulations that selectively inhibit pathogenic strains to advanced delivery systems engineered to provide sustained release of active ingredients. Furthermore, integration of digital health platforms is empowering both practitioners and consumers with real-time tracking of breath quality through smartphone-enabled sensors. As regulatory landscapes evolve to encompass these cutting-edge solutions, stakeholders are increasingly focused on establishing standardized efficacy benchmarks. In this dynamic environment, a comprehensive understanding of both the underlying science and emerging product innovations is essential for guiding strategic investment and fostering improved patient outcomes.

Revolutionary Dynamics Redefining the Halitosis Treatment Landscape Fueled by Technological Advancements, Regulatory Changes, and Consumer Behavior Shifts

Over the past decade, the halitosis treatment ecosystem has undergone transformative shifts driven by breakthroughs in biotechnology and heightened consumer demand for natural and personalized solutions. Technological advancements in peptide-based antimicrobials and nanocarrier delivery systems have enabled precise targeting of malodor-causing bacteria, ushering in formulations with greater efficacy and longer-lasting effects. Simultaneously, accelerated adoption of artificial intelligence and machine learning has enhanced predictive modeling for microbiome composition, allowing researchers to identify at-risk populations and tailor interventions accordingly.

Regulatory frameworks have also evolved to address the complexity of oral care products that claim both therapeutic and cosmetic benefits. Agencies now require more robust clinical evidence to substantiate efficacy claims, prompting manufacturers to undertake rigorous randomized controlled trials and longitudinal studies. Moreover, heightened consumer awareness of ingredient transparency has shifted purchasing decisions toward formulations emphasizing naturally derived extracts and plant-based actives. Online platforms and social media influencers are further amplifying these trends, empowering end users to research ingredient profiles and brand reputations before making informed choices. Together, these technological, regulatory, and consumer-driven forces are redefining competitive dynamics, compelling stakeholders to innovate rapidly and reimagine traditional halitosis management paradigms

Assessing the Far-Reaching Consequences of United States 2025 Tariff Adjustments on Halitosis Prevention Supply Chains, Distribution Networks, and Cost Structures

The announcement of new tariff measures set to take effect in 2025 has introduced an element of uncertainty across global supply chains for halitosis treatment components. Changes in import duties on active ingredients, particularly those sourced from key international suppliers, are expected to influence raw material costs and procurement strategies. Manufacturers that rely on chemical compounds such as cetylpyridinium chloride, triclosan, and zinc salts may need to reevaluate supplier agreements or seek alternative sourcing options in jurisdictions with more favorable trade terms. This realignment has implications not only for cost structures but also for production timelines as lead times shift in response to logistical constraints.

In parallel, distribution networks are adapting to these tariff-driven pressures by optimizing inventory management and exploring nearshoring opportunities to mitigate the impact of fluctuating duties. Organizations with diversified manufacturing footprints are poised to leverage regional facilities to maintain supply continuity and stabilize margins. Retail channels, both brick-and-mortar and digital, are closely monitoring these developments to anticipate changes in retail pricing and consumer demand elasticity. Forward-looking companies are already engaging in scenario planning, assessing the interplay between tariff trajectories, currency fluctuations, and macroeconomic indicators. Through proactive risk assessment and supply chain resiliency measures, industry participants aim to minimize disruptions and preserve the affordability of halitosis management solutions for end users.

Unveiling Critical Market Segmentation Insights Across Components, Products, Disease Types, and Distribution Channels to Guide Strategic Decisions

A nuanced understanding of market segmentation is fundamental for tailoring product portfolios and marketing strategies. Chemical actives continue to dominate component discussions, with cetylpyridinium chloride recognized for its broad-spectrum antimicrobial properties, chlorhexidine valued for its potent bacterial inhibition, triclosan historically employed in diverse oral care formulations, and zinc salts acclaimed for their odor-binding capabilities. Meanwhile, demand for natural alternatives such as essential oils and plant extracts has surged as consumers seek cleaner labels and botanical efficacy. Product segmentation reveals a dynamic equilibrium between immediate delivery formats like breath sprays and chewing gums, which cater to on-the-go freshness, and more sustained treatments including mouthwashes, rinses, tablets, lozenges, and traditional toothpastes designed for daily routines.

Disease type further informs product development as genuine halitosis, encompassing both pathologic and physiologic origins, necessitates clinically proven actives, whereas halitophobia and pseudo-halitosis often require adjunctive psychological support and diagnostic clarity. Distribution channel insights underscore the continued relevance of offline retail through department stores, pharmacy outlets, and supermarkets, while online avenues via brand-owned websites and large-scale e-commerce platforms are rapidly expanding their footprint. This segmentation framework illuminates consumer preferences, guides targeted messaging across diverse channels, and enables stakeholders to align R&D investments with the most promising market niches.

Deciphering Regional Variations in Halitosis Management Trends Across the Americas, Europe Middle East & Africa, and Asia Pacific for Targeted Growth Strategies

Regional dynamics are shaping the global halitosis market as stakeholders adapt strategies to diverse consumer behaviors, regulatory landscapes, and economic conditions. In the Americas, established oral care habits and high disposable incomes drive demand for premium formulations, with North American consumers particularly receptive to innovative delivery systems and clinically validated product claims. Latin American markets are characterized by rising health awareness and growing access to retail channels, offering opportunities for mid-tier brands to capture emerging demand.

Across Europe, the Middle East, and Africa, heterogeneous regulatory frameworks challenge manufacturers to navigate varying approval processes, ingredient restrictions, and labeling requirements. Western European markets emphasize sustainability and natural ingredients, prompting increased investment in plant-based actives. Meanwhile, Gulf Cooperation Council countries demonstrate rapid adoption of online retail for oral care, while African markets prioritize cost-effective solutions due to budget constraints, leading to niche growth for affordable, high-efficacy formulations.

In the Asia Pacific region, cultural practices and traditional medicinal systems influence consumer preferences, with ingredients derived from herbal remedies gaining traction. Rapid urbanization and digital penetration are accelerating e-commerce sales in key markets such as China and India, while Japan and Australia continue to showcase mature markets with rigorous quality standards. These regional insights not only highlight distinct growth drivers but also underscore the need for customized approaches to product formulation, pricing, and distribution to maximize impact in each geography.

Analyzing Leading Industry Players, Strategic Collaborations, and Innovation Trajectories Shaping the Competitive Landscape in Halitosis Solutions Domain

Market leaders are investing heavily in research partnerships and strategic alliances to maintain competitive advantage. Established chemical ingredient manufacturers are collaborating with biotech firms to develop next-generation antimicrobials that target specific halitosis-causing pathogens while preserving the beneficial oral microbiome. Concurrently, natural extract specialists are forming joint ventures with academic institutions to validate the efficacy of essential oils and plant derivatives through rigorous clinical trials, thereby elevating consumer confidence and regulatory acceptance.

Competitive intelligence reveals that several top-tier oral care brands are expanding their portfolios through acquisitions of niche players specializing in breath freshening technologies and oral diagnostic tools. This consolidation trend facilitates rapid integration of novel delivery platforms into mainstream product lines, enabling a seamless transition from laboratory research to mass-market distribution. Companies are also leveraging digital health platforms to offer personalized breath monitoring subscriptions and mobile applications that track long-term user adherence and outcomes. Through these multidimensional strategies, organizations are not only reinforcing existing market positions but also creating new value propositions that resonate with both consumers and healthcare professionals.

In parallel, agile startups are disrupting traditional value chains by introducing direct-to-consumer models that emphasize transparency, subscription-based replenishment, and community-driven feedback loops. Their ability to iterate quickly on product formulations and marketing messages is reshaping consumer expectations and encouraging legacy brands to adopt more consumer-centric innovation frameworks.

Strategic Roadmap for Industry Leaders to Capitalize on Emerging Opportunities and Mitigate Risks in the Evolving Halitosis Treatment Sector

To thrive in this fast-paced environment, industry leaders must implement a multi-pronged growth strategy that balances innovation, operational resilience, and consumer engagement. First, prioritizing investment in advanced formulation technologies such as microencapsulation and time-release systems will provide a competitive edge by delivering sustained freshness while minimizing dosing frequency. Additionally, enhancing supply chain agility through regionally diversified manufacturing facilities can buffer against tariff-related volatility, ensuring product availability and stable costing.

Moreover, integrating digital tools into the customer journey-ranging from mobile breath analysis apps to virtual dental consultations-will strengthen brand loyalty and generate valuable user data for ongoing product optimization. Collaborative research initiatives with academic and clinical partners should be pursued to validate claims and expedite regulatory approvals, particularly for novel actives and natural ingredients. From a marketing perspective, targeted communication that addresses specific consumer segments-whether those seeking immediate freshness solutions or clinical-grade treatment for genuine halitosis-will resonate more effectively when aligned with insights derived from component, product, disease type, and channel analysis.

Finally, sustainability commitments around eco-friendly packaging and responsibly sourced ingredients will not only meet evolving regulatory standards but also appeal to the growing cohort of environmentally conscious consumers. By holistically addressing innovation, supply chain resilience, digital integration, and sustainability, industry leaders can confidently navigate the complexities of the halitosis solutions market and secure long-term growth.

Comprehensive Research Methodology Combining Qualitative Interviews, Quantitative Data Analysis, and Multisource Triangulation to Ensure Robust Insights

This report draws upon a rigorous mixed-methods approach to deliver credible and actionable insights. Primary research involved in-depth interviews with key opinion leaders, including dental professionals, formulation scientists, and supply chain experts, to capture nuanced perspectives on emerging trends, clinical efficacy benchmarks, and commercial innovations. These qualitative inputs were supplemented by extensive quantitative data analysis, which encompassed historical market performance metrics, ingredient utilization rates, and e-commerce sales trajectories. By harmonizing diverse data points, the study identifies prevailing patterns and potential inflection points across the halitosis treatment ecosystem.

Secondary research included systematic reviews of peer-reviewed journals, patent filings, and regulatory filings to track technological advancements and compliance requirements. Additionally, corporate disclosures and investor presentations provided visibility into strategic initiatives, investment flows, and partnership announcements. To enhance reliability, findings from primary and secondary sources underwent rigorous triangulation, wherein inconsistencies were examined and reconciled through follow-up consultations with domain experts. Regional case studies further enriched the analysis by illustrating how macroeconomic factors and cultural preferences shape adoption rates in the Americas, Europe Middle East & Africa, and Asia Pacific.

This comprehensive methodology ensures that the insights presented are grounded in empirical evidence and industry expertise, enabling stakeholders to make informed strategic decisions with confidence.

Synthesizing Key Findings and Forward-Looking Perspectives to Illuminate the Path Ahead for Halitosis Management Innovation and Market Growth

In synthesizing the insights uncovered through this study, it is clear that the halitosis treatment landscape is at an inflection point driven by scientific breakthroughs, shifting regulatory requirements, and evolving consumer preferences. Chemical and natural actives each offer distinct value propositions, and emerging delivery technologies promise to reconcile efficacy with convenience. The looming tariff adjustments in the United States underscore the importance of supply chain versatility, while regional nuances across the Americas, Europe Middle East & Africa, and Asia Pacific highlight the need for market-specific strategies.

Industry participants are increasingly leveraging strategic alliances, digital health integration, and sustainability commitments to differentiate their offerings and strengthen stakeholder trust. Moreover, the granularity provided by component, product, disease type, and channel segmentation lays the groundwork for highly targeted innovation roadmaps and marketing campaigns. As competitive dynamics intensify, success will hinge on an organization's ability to seamlessly align research and development with consumer insights, regulatory expectations, and operational resilience.

Looking forward, continued investment in microbiome research, clinical validation, and personalized solutions will be pivotal in unlocking new growth avenues. By embracing a holistic approach that integrates science, technology, and consumer-centricity, stakeholders can drive meaningful improvements in oral health while capturing significant market opportunities.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Sizing & Forecasting

5. Market Dynamics

• 5.1. Rising demand for probiotic-infused mouth rinses aimed at restoring healthy oral microbiome balance
• 5.2. Growth of personalized oral care regimens leveraging AI diagnostics to address chronic bad breath complaints
• 5.3. Shift towards natural botanical extracts in halitosis formulations driven by consumer wellness trends
• 5.4. Adoption of eco-friendly packaging and refillable formats in mouthwash products to reduce plastic waste
• 5.5. Integration of smart sensor-enabled toothbrushes providing real-time halitosis monitoring and feedback
• 5.6. Expansion of subscription-based direct-to-consumer halitosis solutions featuring curated oral health kits
• 5.7. Increasing collaboration between oral care brands and dental professionals for clinically validated breath solutions
• 5.8. Accelerated innovation in multifunctional toothpaste combining whitening sensitivity relief and breath control

6. Market Insights

• 6.1. Porter's Five Forces Analysis
• 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Halitosis Agent Market, by Component

• 8.1. Introduction
• 8.2. Chemical
  • 8.2.1. Cetylpyridinium Chloride
  • 8.2.2. Chlorhexidine
  • 8.2.3. Triclosan
  • 8.2.4. Zinc Salts
• 8.3. Natural
  • 8.3.1. Essential Oils
  • 8.3.2. Plant Extracts

9. Halitosis Agent Market, by Product

• 9.1. Introduction
• 9.2. Breath Sprays
• 9.3. Chewing Gums
• 9.4. Mouthwashes/Rinses
• 9.5. Tablets/Lozenges
• 9.6. Toothpastes

10. Halitosis Agent Market, by Disease Type

• 10.1. Introduction
• 10.2. Genuine Halitosis
  • 10.2.1. Pathologic Halitosis
  • 10.2.2. Physiologic Halitosis
• 10.3. Halitophobia
• 10.4. Pseudo-Halitosis

11. Halitosis Agent Market, by Distribution Channel

• 11.1. Introduction
• 11.2. Offline
  • 11.2.1. Department Stores
  • 11.2.2. Pharmacy Stores
  • 11.2.3. Supermarkets
• 11.3. Online
  • 11.3.1. Brand Websites
  • 11.3.2. E-commerce Platforms

12. Americas Halitosis Agent Market

• 12.1. Introduction
• 12.2. United States
• 12.3. Canada
• 12.4. Mexico
• 12.5. Brazil
• 12.6. Argentina

13. Europe, Middle East & Africa Halitosis Agent Market

• 13.1. Introduction
• 13.2. United Kingdom
• 13.3. Germany
• 13.4. France
• 13.5. Russia
• 13.6. Italy
• 13.7. Spain
• 13.8. United Arab Emirates
• 13.9. Saudi Arabia
• 13.10. South Africa
• 13.11. Denmark
• 13.12. Netherlands
• 13.13. Qatar
• 13.14. Finland
• 13.15. Sweden
• 13.16. Nigeria
• 13.17. Egypt
• 13.18. Turkey
• 13.19. Israel
• 13.20. Norway
• 13.21. Poland
• 13.22. Switzerland

14. Asia-Pacific Halitosis Agent Market

• 14.1. Introduction
• 14.2. China
• 14.3. India
• 14.4. Japan
• 14.5. Australia
• 14.6. South Korea
• 14.7. Indonesia
• 14.8. Thailand
• 14.9. Philippines
• 14.10. Malaysia
• 14.11. Singapore
• 14.12. Vietnam
• 14.13. Taiwan

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. Chattem, Inc.
  • 15.3.2. Church & Dwight Co., Inc.
  • 15.3.3. Colgate-Palmolive Company
  • 15.3.4. Dabur India Limited
  • 15.3.5. Dentaid S.L.
  • 15.3.6. Dental Herb Company
  • 15.3.7. Dr. Harold Katz, LLC
  • 15.3.8. GlaxoSmithKline PLC
  • 15.3.9. Hello Products LLC
  • 15.3.10. Johnson & Johnson
  • 15.3.11. Kao Corporation
  • 15.3.12. Kerr Corporation
  • 15.3.13. Koninklijke Philips N.V.
  • 15.3.14. Lion Corporation
  • 15.3.15. OraLabs, Inc.
  • 15.3.16. Patanjali Ayurved Ltd.
  • 15.3.17. PerioSciences
  • 15.3.18. Procter & Gamble Co.
  • 15.3.19. Rowpar Pharmaceuticals, Inc
  • 15.3.20. Sunstar Suisse S.A.
  • 15.3.21. Tom's of Maine, Inc.
  • 15.3.22. Unilever PLC
  • 15.3.23. Viatris Inc.
  • 15.3.24. Zendium
  • 15.3.25. Zila, Inc.

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix